Legalon-SIL downregulates HCV core and NS5A in human hepatocytes expressing full-length HCV

doi:10.3748/wjg.v17.i13.1694

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 13

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4260)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series.

Item

Count

PDF

329

HTML

3669

Figures (1-6)

262

Sum=4260

Apr 7, 2011 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Apr 7, 2011; 17(13): 1694-1700
Published online Apr 7, 2011. doi: 10.3748/wjg.v17.i13.1694

Full Size Figure Download Figure

Figure 1 Effects of legalon-SIL on CON1 cell viability. Cellular viability of CON1 cells was measured using the propidium iodide assay after 4, 8, and 24 h of exposure to legalon-SIL (LS) at varying concentrations ranging from 0-500 μm/L. The mean ± SE from 3 independent experiments. ^aP < 0.05 vs DMSO control.

Citation: Mehrab-Mohseni M, Sendi H, Steuerwald N, Ghosh S, Schrum LW, Bonkovsky HL. Legalon-SIL downregulates HCV core and NS5A in human hepatocytes expressing full-length HCV. World J Gastroenterol 2011; 17(13): 1694-1700
URL: https://www.wjgnet.com/1007-9327/full/v17/i13/1694.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i13.1694